Publications by authors named "G N Bischof"

Purpose: This two-arm cluster randomized controlled trial evaluated the effectiveness of an app-based addiction prevention program in German vocational school students.

Methods: Schools from 5 German federal states were recruited. No eligibility criteria for classes were applied; enrollment decisions were made by school heads or teachers.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigated the relationship between tau pathology in specific brain regions and apraxia symptoms in Alzheimer's disease (AD) patients, using PET imaging to assess tau deposition.
  • Researchers hypothesized that certain areas with tau buildup would correlate with the severity of apraxia, a common cognitive dysfunction in AD.
  • Findings revealed significant correlations between tau aggregation in specific praxis-related brain regions and apraxia severity, while no connections were found in primary motor cortex or subcortical regions.
View Article and Find Full Text PDF

Tau PET has attracted increasing interest as an imaging biomarker for 4-repeat (4R)-tauopathy progressive supranuclear palsy (PSP). However, the translation of in vitro 4R-tau binding to in vivo tau PET signals is still unclear. Therefore, we performed a translational study using a broad spectrum of advanced methodologies to investigate the sources of [F]PI-2620 tau PET signals in individuals with 4R-tauopathies, including a pilot PET autopsy study in patients.

View Article and Find Full Text PDF

Several studies have demonstrated strong agreement between routine clinical visual assessment and quantification, suggesting that quantification approaches could support assessment by less experienced readers or in challenging cases. However, all studies to date have implemented a retrospective case collection, and challenging cases were generally underrepresented. We included all participants ( = 741) from the AMYPAD diagnostic and patient management study with available baseline amyloid PET quantification.

View Article and Find Full Text PDF

Aquaporin-4 (AQP4) is hypothesized to be a component of the glymphatic system, a pathway for removing brain interstitial solutes like amyloid-β (Aβ). Evidence exists that genetic variation of AQP4 impacts Aβ clearance, clinical outcome in Alzheimer's disease as well as sleep measures. We examined whether a risk score calculated from several AQP4 single-nucleotide polymorphisms (SNPs) is related to Aβ neuropathology in older cognitively unimpaired white individuals.

View Article and Find Full Text PDF